OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
Tran Dang Nguyen, Bo Gao, Chanaki Amaratunga, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Tran Dang Nguyen, Bo Gao, Chanaki Amaratunga, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
The emergence of artemisinin partial resistance in Africa: how do we respond?
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43
Philip J. Rosenthal, Victor Asua, Jeffrey A. Bailey, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e591-e600
Open Access | Times Cited: 43
Dual-targeting nanozyme combined with aPD-L1-based immunotherapy for combating cancer recurrence and metastasis
Lu Tang, Yuqi Cao, Yue Yin, et al.
Materials Today (2024) Vol. 73, pp. 79-95
Closed Access | Times Cited: 25
Lu Tang, Yuqi Cao, Yue Yin, et al.
Materials Today (2024) Vol. 73, pp. 79-95
Closed Access | Times Cited: 25
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
Robert Zupko, Tran Dang Nguyen, Jean Claude Semuto Ngabonziza, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2775-2784
Open Access | Times Cited: 25
Robert Zupko, Tran Dang Nguyen, Jean Claude Semuto Ngabonziza, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2775-2784
Open Access | Times Cited: 25
Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Wei‐Fang Zuo, Qiwen Pang, Xinyu Zhu, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Unraveling the secrets: Evolution of resistance mediated by membrane proteins
Xue Yang, Min Li, Zi-Chang Jia, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101140-101140
Open Access | Times Cited: 10
Xue Yang, Min Li, Zi-Chang Jia, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101140-101140
Open Access | Times Cited: 10
Towards next-generation treatment options to combat Plasmodium falciparum malaria
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9
John Okombo, David A. Fidock
Nature Reviews Microbiology (2024)
Closed Access | Times Cited: 9
Artemisinin-resistant malaria
Nicholas J. White, Kesinee Chotivanich
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 9
Nicholas J. White, Kesinee Chotivanich
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 9
Tuberculosis preventive therapy: scientific and ethical considerations for trials of ultra-short regimens
Timothy M. Walker, James A Watson, David Moore, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Timothy M. Walker, James A Watson, David Moore, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Supramolecular 3 in 1: A Lubrication and Co-Delivery System for Synergistic Advanced Osteoarthritis Therapy
Mengmeng Chen, Y H Li, Yu‐Jie Zhu, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 13117-13129
Closed Access | Times Cited: 7
Mengmeng Chen, Y H Li, Yu‐Jie Zhu, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 13117-13129
Closed Access | Times Cited: 7
Alarming Plasmodium falciparum resistance to artemisinin-based combination therapy in Africa: the critical role of the partner drug
Anders Björkman, José Pedro Gil, Michael Alifrangis
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e540-e541
Closed Access | Times Cited: 5
Anders Björkman, José Pedro Gil, Michael Alifrangis
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 9, pp. e540-e541
Closed Access | Times Cited: 5
Structural comparison of human and Plasmodium proteasome β5 subunits: informing selective inhibitor design for anti-malaria agents
Muhammad Yasir, Jin‐Young Park, Eun‐Taek Han, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Muhammad Yasir, Jin‐Young Park, Eun‐Taek Han, et al.
Malaria Journal (2025) Vol. 24, Iss. 1
Open Access
Isoliquiritigenin from licorice root: A multi-stage anti-malarial with synergistic impact on multidrug-resistant P. falciparum
Saurabh Kumar, Deepak Singh Kapkoti, Pooja Rani Mina, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100396-100396
Open Access | Times Cited: 3
Saurabh Kumar, Deepak Singh Kapkoti, Pooja Rani Mina, et al.
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 10, pp. 100396-100396
Open Access | Times Cited: 3
Evaluation of the Quality of Artemether-Lumefantrine-based Antimalarials from the Illicit Ivorian Market in West Africa
Jean-Paul Déto Ursul N'Guessan, Songuigama Coulibaly, Alain Kacou, et al.
International Journal of Pharmacy and Chemistry (2025) Vol. 11, Iss. 1, pp. 22-30
Open Access
Jean-Paul Déto Ursul N'Guessan, Songuigama Coulibaly, Alain Kacou, et al.
International Journal of Pharmacy and Chemistry (2025) Vol. 11, Iss. 1, pp. 22-30
Open Access
Identification of a Class of Iron-Grabbing Compounds with Antiplasmodial Activity: Impact of Coordination Structures and Electronic Regularity on the Intraerythrocytic Growth Cycle of Plasmodium falciparum
Akira Wada, Hiroko Asahi
ACS Infectious Diseases (2025)
Closed Access
Akira Wada, Hiroko Asahi
ACS Infectious Diseases (2025)
Closed Access
In vitro antiplasmodial activity and cytotoxicity of three Ziziphus (Rhamnaceae) species from South Africa
Mcebisi Junior Mabuza, Marcel Kaiser, T.E. Tshikalange, et al.
Journal of Ethnopharmacology (2025), pp. 119918-119918
Open Access
Mcebisi Junior Mabuza, Marcel Kaiser, T.E. Tshikalange, et al.
Journal of Ethnopharmacology (2025), pp. 119918-119918
Open Access
Recent Advances in Diagnostics and Therapeutic Interventions for Drug-Resistant Malaria
K.C. Barman, Pranab Goswami
ACS Infectious Diseases (2025)
Closed Access
K.C. Barman, Pranab Goswami
ACS Infectious Diseases (2025)
Closed Access
Innovative approaches in the discovery of terpenoid natural products
Shu Cheng, Xinghuan Wang, Zixin Deng, et al.
Current Opinion in Microbiology (2024) Vol. 83, pp. 102575-102575
Closed Access | Times Cited: 3
Shu Cheng, Xinghuan Wang, Zixin Deng, et al.
Current Opinion in Microbiology (2024) Vol. 83, pp. 102575-102575
Closed Access | Times Cited: 3
Breaking the cycle of malaria treatment failure
Maciej F. Boni
Frontiers in Epidemiology (2022) Vol. 2
Open Access | Times Cited: 13
Maciej F. Boni
Frontiers in Epidemiology (2022) Vol. 2
Open Access | Times Cited: 13
Discovery of new piperaquine hybrid analogs linked by triazolopyrimidine and pyrazolopyrimidine scaffolds with antiplasmodial and transmission blocking activities
Lívia M. Feitosa, Rodolfo Rodrigo F. França, M.De L. Ferreira, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116163-116163
Closed Access | Times Cited: 2
Lívia M. Feitosa, Rodolfo Rodrigo F. França, M.De L. Ferreira, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116163-116163
Closed Access | Times Cited: 2
In vitro evaluation of ganaplacide/lumefantrine combination against Plasmodium falciparum in a context of artemisinin resistance
Jeanne Manaranche, Marion Laurent, Roxane Tressieres, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 11, pp. 2877-2886
Open Access | Times Cited: 2
Jeanne Manaranche, Marion Laurent, Roxane Tressieres, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 11, pp. 2877-2886
Open Access | Times Cited: 2
Biogenically synthesized green silver nanoparticles exhibit antimalarial activity
Savitri Tiwari, Reetesh Kumar, Sonia Devi, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Savitri Tiwari, Reetesh Kumar, Sonia Devi, et al.
Discover Nano (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reducePlasmodium falciparummalaria transmission in Ouélessébougou, Mali: a five-arm, phase 2, single-blind, randomised clinical trial
Almahamoudou Mahamar, Leen N. Vanheer, Merel Smit, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
Almahamoudou Mahamar, Leen N. Vanheer, Merel Smit, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 2
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review
Nadine Kalenda Kayiba, Evariste Tshibangu‐Kabamba, Angel Rosas‐Aguirre, et al.
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 5
Nadine Kalenda Kayiba, Evariste Tshibangu‐Kabamba, Angel Rosas‐Aguirre, et al.
Tropical Medicine and Health (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 5
Bridging the Gap from Molecular Surveillance to Programmatic Decisions for Malaria Control and Elimination
Monica Golumbeanu, Constant Edi, Manuel W. Hetzel, et al.
American Journal of Tropical Medicine and Hygiene (2023)
Open Access | Times Cited: 4
Monica Golumbeanu, Constant Edi, Manuel W. Hetzel, et al.
American Journal of Tropical Medicine and Hygiene (2023)
Open Access | Times Cited: 4
